Internal Medicine, Infectious Disease · Oklahoma City, OK
NPI
1346406899
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
4221 S Western Ave, Ste 4010
Oklahoma City, OK, 73109
Phone (405) 644-6464
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
32,098 services
Medicare patients, 2024
364
Average age 71
Drug cost, 2024
$2.3M
1,701 prescriptions
Company payments, 2025
$831
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrea R Scott was code 99233 (hospital e&m - subsequent), 339 times for 115 patients. In total Andrea R Scott billed 32,098 services in 37 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 339 | 115 | $88.89 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 212 | 106 | $59.29 | $13K |
| 99223 Hospital E&M - Initial | Facility | 204 | 184 | $126.19 | $26K |
| 99214 Office E&M - Established | Office | 177 | 95 | $90.89 | $16K |
| 96365 Intravenous Infusion, Hydration | Office | 84 | 12 | $44.78 | $3,762 |
| 99213 Office E&M - Established | Office | 50 | 43 | $54.57 | $2,729 |
| 99211 Office E&M - Established | Office | 34 | 16 | $16.46 | $560 |
| 99204 Office E&M - New | Office | 21 | 21 | $122.42 | $2,571 |
By year: 2022 $109K for 4,006 services; 2023 $107K for 4,284 services; 2024 $104K for 32,098 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrea R Scott prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 158 prescriptions and refills. In total Andrea R Scott wrote 1,701 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 158 | 158 | 16 | $623K |
| Descovy Emtricitabine/Tenofov Alafenam | 108 | 108 | Under 11 | $238K |
| Cephalexin Generic | 99 | 103 | 27 | $3,560 |
| Doxycycline Hyclate Generic | 85 | 87 | 29 | $2,067 |
| Ritonavir Generic | 70 | 78 | Under 11 | $10K |
| Daptomycin Generic | 54 | 54 | 14 | $12K |
| Tivicay Dolutegravir Sodium | 54 | 54 | Under 11 | $118K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 51 | 51 | Under 11 | $190K |
| Prezcobix Darunavir/Cobicistat | 49 | 49 | Under 11 | $115K |
| Darunavir Generic | 39 | 39 | Under 11 | $24K |
| Ciprofloxacin Hcl Generic | 37 | 37 | 12 | $1,273 |
| Atazanavir Sulfate Generic | 37 | 47 | Under 11 | $8,678 |
| Vancomycin Hcl Generic | 37 | 37 | Under 11 | $3,731 |
| Isentress Raltegravir Potassium | 36 | 36 | Under 11 | $68K |
| Acyclovir Generic | 36 | 40 | Under 11 | $339 |
Brand drugs: 587 claims; generic drugs: 1,114 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrea R Scott $831 ($831 in general payments such as food, travel and fees) from 8 companies. The largest payer was Gilead Sciences, Inc. with $262.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.